Cancer Family
Neuroepithelial, Perineurial, and Schwann Cell Neoplasm
CI-CAN-00000039Explore in graph →
Non-malignant864 active trials6 approved drugs159 evidence items
- NCIt
- C35562
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000039Explore in graph →
Clinical trials
3,131 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04417868 | Evolution of Cochleovestibular Schwannomas | unknown | — | 140 | University Hospital, Strasbourg, FranceOTHER | 1 | Jun 11, 2020 | clinicaltrials |
| NCT04417933 | Tumor Electric Fields Treatment System for Glioblastoma | unknown | Early Phase 1 | 5 | Xiangya Hospital of Central South UniversityOTHER | 1 | Jun 11, 2020 | clinicaltrials |
| NCT04425798 | Connectivity Alterations After Levetiracetam Application | unknown | — | 30 | Beijing Neurosurgical InstituteOTHER | 1 | Jun 11, 2020 | clinicaltrials |
| NCT04388033 | Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients. | unknown | Phase 1 / Phase 2 | 10 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jun 9, 2020 | clinicaltrials |
| NCT01649830 | Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma | unknown | Phase 3 | 290 | Sun Yat-sen UniversityOTHER | 1 | May 28, 2020 | clinicaltrials |
| NCT04045847 | CD147-CART Cells in Patients With Recurrent Malignant Glioma. | unknown | Early Phase 1 | 31 | Xijing HospitalOTHER | 1 | May 7, 2020 | clinicaltrials |
| NCT02077543 | Multicenter Safety Trial Assessing an Innovative Tumor Molecular and Cellular Print Medical Device in Glioma(ProTool) | unknown | Early Phase 1 | 150 | University Hospital, GrenobleOTHER | 1 | Mar 25, 2020 | clinicaltrials |
| NCT04315584 | FDG and FDOPA PET Demonstration of Functional Brain Abnormalities | unknown | Early Phase 1 | 5 | University of VirginiaOTHER | 1 | Mar 24, 2020 | clinicaltrials |
| NCT04313842 | A Explorative Study to Evaluate the Clinical Feasibility of AVATAMED | unknown | — | 40 | Doo-Sik KongOTHER | 1 | Mar 18, 2020 | clinicaltrials |
| NCT04277221 | ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM) | unknown | Phase 3 | 118 | Safe Save Medical Cell Sciences & Technology Co.,Ltd.INDUSTRY | 1 | Mar 17, 2020 | clinicaltrials |
| NCT02715297 | Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma(GlioCave/NOA17) | unknown | Phase 2 | 162 | Technical University of MunichOTHER | 1 | Mar 10, 2020 | clinicaltrials |
| NCT03567135 | Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma | unknown | — | 60 | Fuzhou General HospitalOTHER | 1 | Mar 3, 2020 | clinicaltrials |
| NCT04284306 | Immunohistochemical Assessment of Programmed Death ligand1 and LC3B in GBM | unknown | — | 61 | Assiut UniversityOTHER | 0 | Feb 25, 2020 | clinicaltrials |
| NCT03739333 | Early Diagnosis of Pseudoprogression Using 11C-Methionine PET-MRI After Concomitant Radiochemotherapy Treatment for Glioblastoma.(TIGRE) | unknown | N/A | 40 | Hospices Civils de LyonOTHER | 1 | Feb 13, 2020 | clinicaltrials |
| NCT04122521 | Radiogenomic and Prognosis Analysis in Glioma | unknown | — | 62 | Asan Medical CenterOTHER | 1 | Feb 7, 2020 | clinicaltrials |
| NCT03531333 | Intraoperative Ultrasound Guided Glioma Surgery; a Randomised, Controlled Trial.(US-GLIOMA) | unknown | N/A | 50 | Erasmus Medical CenterOTHER | 1 | Jan 13, 2020 | clinicaltrials |
| NCT04224441 | Repurposing Chlorpromazine in the Treatment of Glioblastoma(RACTAC) | unknown | Phase 2 | 41 | Marco G Paggi, MD, PhDOTHER | 1 | Jan 13, 2020 | clinicaltrials |
| NCT03638206 | Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies | unknown | Phase 1 / Phase 2 | 73 | Shenzhen BinDeBio Ltd.INDUSTRY | 1 | Dec 11, 2019 | clinicaltrials |
| NCT04194593 | Biomarker-based Algorithm for Diagnosis of Glioma(TELOGNOSTIC) | unknown | — | 300 | Hospices Civils de LyonOTHER | 1 | Dec 11, 2019 | clinicaltrials |
| NCT04157478 | Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma | unknown | Phase 2 | 464 | People's Hospital of Guangxi Zhuang Autonomous RegionOTHER | 1 | Nov 12, 2019 | clinicaltrials |
| NCT04128345 | Novel Multimodality Imaging for Navigation in Skull Base Surgery(SBN) | unknown | — | 20 | University College, LondonOTHER | 1 | Oct 16, 2019 | clinicaltrials |
| NCT04101409 | Impact of Shared Decision-Making With Decision Aids on Acoustic Neuroma Treatment Choice: A Randomized Controlled Trial | unknown | N/A | 78 | Taipei Medical University Shuang Ho HospitalOTHER | 0 | Sep 24, 2019 | clinicaltrials |
| NCT02391246 | Radionecrosis and FDG PET(DTPI FDG-PET) | unknown | — | 62 | Ottawa Hospital Research InstituteOTHER | 1 | Aug 28, 2019 | clinicaltrials |
| NCT03997136 | Prognostic Impact of Surgical Resection Extent for Supratentorial High Grade Gliomas. | unknown | — | 28 | Assiut UniversityOTHER | 0 | Aug 7, 2019 | clinicaltrials |
| NCT03741244 | TMZ Plus Apatinib in Newly Diagnosed High-grade Glioma：RCT | unknown | Phase 2 | 211 | The Second Hospital of Hebei Medical UniversityOTHER | 1 | Jul 23, 2019 | clinicaltrials |
| NCT02520635 | Supra-early Post-Surgery Chemotherapy in the Treatment on GBM Patients | unknown | — | 180 | Beijing Tiantan HospitalOTHER | 1 | Jul 11, 2019 | clinicaltrials |
| NCT03392545 | Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1)(InSituVac1) | unknown | Phase 1 | 30 | Beijing Tiantan HospitalOTHER | 1 | Jul 11, 2019 | clinicaltrials |
| NCT04004377 | Acoustic Neuroma: Assessing the Quality of Life by the Scale PANQOL of Patients Operated or Supervised(PANQOL) | unknown | — | 200 | University Hospital, BordeauxOTHER | 1 | Jul 2, 2019 | clinicaltrials |
| NCT04004975 | Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib | unknown | Phase 1 / Phase 2 | 50 | Shandong Cancer Hospital and InstituteOTHER | 1 | Jul 2, 2019 | clinicaltrials |
| NCT03971812 | Organoids Derived From Induced-Pluripotent Stem Cells (iPS) From Patients With High Grade Astrocytoma(GLIOMANOID) | unknown | — | 20 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Jun 13, 2019 | clinicaltrials |
| NCT03970681 | Clinical and Radiological Evaluation of Acoustic Neuromas With Spontaneous Shrinkage | unknown | — | 40 | University Hospital, Strasbourg, FranceOTHER | 1 | May 31, 2019 | clinicaltrials |
| NCT03916757 | V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer(GBM) | unknown | Phase 2 | 20 | Immunitor LLCINDUSTRY | 1 | Apr 17, 2019 | clinicaltrials |
| NCT03690570 | Long Term Follow up of Patients Under 5 Years of Age With High Grade Glioma Diagnosed in France Between 1990 and 2015(GlioUnder5) | unknown | — | 50 | University Hospital, Strasbourg, FranceOTHER | 1 | Apr 4, 2019 | clinicaltrials |
| NCT03869242 | NovoTTF-200A Together With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GBM(NovoTTF-200A) | unknown | N/A | 60 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Mar 11, 2019 | clinicaltrials |
| NCT03687034 | A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma | unknown | Phase 1 | 21 | Leaf Vertical Inc.INDUSTRY | 0 | Feb 26, 2019 | clinicaltrials |
| NCT02209428 | A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas | unknown | Phase 2 | 54 | Huashan HospitalOTHER | 1 | Feb 21, 2019 | clinicaltrials |
| NCT03091270 | ZOOMit-fMRI Identifies Motor Functional Cortex | unknown | — | 60 | Beijing Neurosurgical InstituteOTHER | 1 | Jan 16, 2019 | clinicaltrials |
| NCT03780569 | TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM | unknown | N/A | 10 | NovoCure Ltd.INDUSTRY | 1 | Dec 20, 2018 | clinicaltrials |
| NCT03642080 | MRI Predictors of Response to Tumor Treating Fields | unknown | — | 48 | New York Presbyterian Brooklyn Methodist HospitalOTHER | 1 | Dec 19, 2018 | clinicaltrials |
| NCT02652897 | Hemostasis Alterations in Neurosurgical Patients(ABCD) | unknown | — | 120 | Santiago R. Leal-NovalOTHER | 1 | Nov 27, 2018 | clinicaltrials |
| NCT03746288 | To Evaluate the Efficacy and Safety of CAN008 Combined With Re-irradiation (rRT) for Treating Patients With Recurrent Glioblastoma (GBM) | unknown | Phase 2 | 60 | CANbridge Life Sciences Ltd.INDUSTRY | 0 | Nov 19, 2018 | clinicaltrials |
| NCT03716986 | Multimodal Imaging of Hypoxia in Gliomas(GLIOXYMAGE) | unknown | N/A | 20 | University Hospital, CaenOTHER | 1 | Oct 23, 2018 | clinicaltrials |
| NCT02933333 | G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor | unknown | Phase 4 | 405 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Oct 17, 2018 | clinicaltrials |
| NCT03641391 | Awake Intraoperative Language Mapping and Chinese Probabilistic Map Construction | unknown | N/A | 300 | Huashan HospitalOTHER | 1 | Aug 22, 2018 | clinicaltrials |
| NCT03631836 | Phase I Study of Monoclonal Antibondy (GS) 5745, an Matix Metalloproteinase 9 (MMP9) Mab Inhibitor, in Combination With Bevacizumab in Patients With Recurrent Glioblastoma(MARELLE01) | unknown | Phase 1 | 34 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Aug 17, 2018 | clinicaltrials |
| NCT03633552 | Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma | unknown | Phase 3 | 62 | Mashhad University of Medical SciencesOTHER | 1 | Aug 16, 2018 | clinicaltrials |
| NCT03631823 | Gut Microbiota and Glioblastoma Multiforme Prognosis | unknown | — | 200 | Huashan HospitalOTHER | 0 | Aug 15, 2018 | clinicaltrials |
| NCT03607643 | A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies | unknown | Phase 1 / Phase 2 | 160 | Leaf Vertical Inc.INDUSTRY | 1 | Jul 31, 2018 | clinicaltrials |
| NCT02233049 | Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication(BIOMEDE) | unknown | Phase 2 | 250 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jul 23, 2018 | clinicaltrials |
| NCT03593577 | Secondary Endolymphatic Hydrops and Vestibular Schwannomas on 3 Tesla MRI | unknown | — | 185 | University Hospital, Strasbourg, FranceOTHER | 1 | Jul 20, 2018 | clinicaltrials |
Data updated 23 days agoSource updated Jun 11, 2020source: clinicaltrials